Diagnostic Pathology: Cardiovascular | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
A01=Dylan V. Miller
A01=Monica P. Revelo
Age Group_Uncategorized
Age Group_Uncategorized
Author_Dylan V. Miller
Author_Monica P. Revelo
automatic-update
Category1=Non-Fiction
Category=MMF
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Diagnostic Pathology: Cardiovascular

English

By (author): Dylan V. Miller Monica P. Revelo

This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all aspects of cardiovascular pathology, including new cardiac devices, molecular panels and genetics, the latest tumor classifications, up-to-date COVID-19 information, and imaging, this volume incorporates the most recent scientific and technical knowledge in the field to provide a comprehensive overview of all key issues relevant to today's practice. Richly illustrated and easy to use, the third edition of Diagnostic Pathology: Cardiovascular is a visually stunning, one-stop resource for every practicing pathologist, resident, student, or fellow as an ideal day-to-day reference or as a reliable training resource. Covers all areas of cardiovascular pathology, organizing chapters by how specimens are most often encountered in practice-biopsy, explant and surgical specimens, and autopsy-as well as by anatomic site  Contains significantly updated information throughout (text, images, illustrations, and references) including the latest World Health Organization and International Collaboration on Cancer Reporting tumor classifications, as well as new details related to staging and grading of tumors of the heart, and COVID-19 information  Evaluates a new generation of cardiac devices in surgical and autopsy specimens in both images and text  Includes new material on genetics and sudden cardiac death and cardiomyopathy, and recent recommended amyloid treatment therapies  Features nearly 1,500 images, including carefully annotated histology and gross pathology photographs, vivid medical illustrations, photomicrographs, and electron micrographs to help practicing and in-training pathologists reach a confident diagnosis  Employs consistently templated chapters, bulleted content, key facts, a variety of tables, annotated images, pertinent references, and an extensive index for quick, expert reference at the point of care  Includes an eBook version?that enables you to access all text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud  See more
Current price €191.89
Original price €201.99
Save 5%
A01=Dylan V. MillerA01=Monica P. ReveloAge Group_UncategorizedAuthor_Dylan V. MillerAuthor_Monica P. Reveloautomatic-updateCategory1=Non-FictionCategory=MMFCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 1700g
  • Dimensions: 216 x 276mm
  • Publication Date: 04 May 2023
  • Publisher: Elsevier - Health Sciences Division
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780323936200

About Dylan V. MillerMonica P. Revelo

Dylan V. Miller is a Professor (Clinical) at the University of Utah School of Medicine's Department of Pathology and is Director of Electron Microscopy and Immunostains at Intermountain Central Laboratory in Salt Lake City Utah Monica P. Revelo is a Professor at the University of Utah School of Medicine's Department of Pathology and is Medical Director of Renal and Cardiovascular Pathology at ARUP Laboratories in Salt Lake City Utah

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept